Nafis Rahman
MD, PhD
nafrah@utu.fi +358 29 450 4637 +358 50 477 3022 Kiinamyllynkatu 10 Turku Office: C505A ORCID identifier: https://orcid.org/0000-0001-5257-870X |
endocrine-related cancer; gonadotropins; hypothalamus-pituitary-gonadal axis; ardenocortical tumours; novel treatment strategies
Docent of Physiology, University of Turku, Turku, Finland (2005) & Docent of Medicine, Medical University of Bialystok, Poland (2016); Doctor of Medical Sciences (Ph.D.), Medical University of Lodz, Poland (1995); Specialization in Obstetrics & Gynecology, Medical University of Lodz, Poland (1995); Licentiate in Medicine, Medical University of Lodz, Poland (1991)
Working at the University of Turku: from 1996 -
Postdoctoral training: Prof Ilpo Huhtaniemi group 1996 - 1998
Visiting professorships Current: Medical University of Bialystok, Bialystok, Poland; Former: FIU College of Medicine, Miami, FL, USA
Editor in chief from 2016 https://www.journals.elsevier.com/reproductive-biology/
Our study the underlying molecular mechanisms of hormonally regulated cancers (i.e. prostate, ovarian, testicular and adrenocortical), search for their novel biomarkers and treatment. We recently tested the potential of tumor specific zona pellucida antigen-3 immunization to enhance therapeutic effects in several hormonally regulated cancers. We have used successfully conjugated lytic peptides to eradicate only cancer cells through their specific gonadotropin receptors (such as lhcgr). We use transgenic murine endocrine cancer metastatic disease models and immortalized cell lines to test the feasibility of novel treatment strategies starting at cellular, in vivo in TG mice and finally aim for human clinical trials.
Teach at the University of Turku, Faculty of Medicine, medical curriculum students: Physiology, Endocrinology, reproductive Endocrinology; Reproductive Biology courses
Received the teacher of the year award (Vuoden Opettaja) in 2005 from the Student Union & Rector of the University of Turku.
- Cyanidin-3-o-Glucoside Pharmacologically Inhibits Tumorigenesis via Estrogen Receptor β in Melanoma Mice (2019)
- Frontiers in Oncology
(A1 Refereed original research article in a scientific journal) - Erratum: Functional Characterization of MicroRNA-27a-3p Expression in Human Polycystic Ovary Syndrome" (Endocrinology (2018) 159:1 (297-309) DOI: 10.1210/en.2017-00219) (2019)
- Endocrinology
(Other publication) - Extragonadal FSHR Expression and Function—Is It Real? (2019)
- Frontiers in Endocrinology
(A2 Refereed review article in a scientific journal ) - Features of the fetal gonad in androgen synthesis in the postpubertal testis are preserved in complete androgen insensitivity syndrome due to a novel genetic splice site donor variant in androgen receptor gene intron 1 (2019)
- Journal of Steroid Biochemistry and Molecular Biology
(A1 Refereed original research article in a scientific journal) - GnRH antagonist treatment of malignant adrenocortical tumors (2019)
- Endocrine-Related Cancer
(A1 Refereed original research article in a scientific journal) - Lipopolysaccharide disrupts gap junctional intercellular communication in an immortalized ovine luteal endothelial cell line (2019)
- Toxicology in Vitro
(A1 Refereed original research article in a scientific journal) - Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progression (2019)
- EBioMedicine
(A1 Refereed original research article in a scientific journal) - Mouse models of adrenal tumors responsive to gonadotropin-releasing hormone and gonadotropins (2019)
- Current Opinion in Endocrine and Metabolic Research
(A2 Refereed review article in a scientific journal ) - Constitutively active follicle-stimulating hormone receptor enables androgen-independent spermatogenesis (2018)
- Journal of Clinical Investigation
(A1 Refereed original research article in a scientific journal) - Functional Characterization of MicroRNA-27a-3p Expression in Human Polycystic Ovary Syndrome (2018)
- Endocrinology
(A1 Refereed original research article in a scientific journal)



